Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company HealthLinx Ltd.
DescriptionFragment of a naturally occurring protein shown to inhibit a key protein that controls vascular leakage induced by a wide variety of proinflammatory factors
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory distress syndrome (RDS)
Indication DetailsTreat respiratory distress syndrome (RDS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today